NCT02663479已完成1 期
Proprietary Lipid-Lowering Nutraceutical Supplement in the Management of Hypertension
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Blood Pressure
研究概览
简要总结
The purpose of this study is to evaluate the efficacy and safety of a proprietary nutraceutical supplement in capsule form over 4 months in treating blood pressure in a group of chronic hypertensive subjects that are not receiving any pharmaceutical anti-hypertensive agents or other nutraceutical supplements.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Blood Pressure
时间窗: 4 months
Reduction in systolic and diastolic blood pressure as measured by office readings and 24 hour ABM ( ambulatory blood pressure monitor)
次要结局
- Endothelial Function(4 months)
- Small arterial compliance(4 months)
- Large arterial compliance(4 months)
- Central arterial blood pressure(4 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
LDL-cholesterol Lowering Effect of a New Dietary SupplementHypercholesterolemiaNCT03425630Ispharm srl20
已完成
不适用
Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory MarkersHealthy VolunteersNCT03118583Midwest Center for Metabolic and Cardiovascular Research12
已完成
不适用
Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish OilHealthyMildly Elevated Cholesterol LevelsNCT01313988Unilever R&D332
Unknown
3 期
The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients' Lipid ProfilesHyperlipidemiaNCT00316641China Medical University Hospital
已完成
不适用
Lipid Formulation to Increase the Bioavailability of Fatty Acids in Cystic Fibrosis (CF) PatientsCystic FibrosisNCT02646995Société des Produits Nestlé (SPN)16